N-[[4-(4-cyanophenyl)-2-pyridinyl]methyl]-1-[(5-fluoro-1-benzofuran-2-yl)sulfonyl]pyrrolidine-2-carboxamide
C26H21FN4O4S — CID 122696042
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[4-(4-cyanophenyl)-2-pyridinyl]methyl]-1-[(5-fluoro-1-benzofuran-2-yl)sulfonyl]pyrrolidine-2-carboxamide
N-[[4-(4-cyanophenyl)-2-pyridinyl]methyl]-1-[(5-fluoro-1-benzofuran-2-yl)sulfonyl]pyrrolidine-2-carboxamide (PubChem CID 122696042) has the molecular formula C26H21FN4O4S and a molecular weight of 504.54 g/mol. Its IUPAC name is N-[[4-(4-cyanophenyl)-2-pyridinyl]methyl]-1-[(5-fluoro-1-benzofuran-2-yl)sulfonyl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | N-[[4-(4-cyanophenyl)-2-pyridinyl]methyl]-1-[(5-fluoro-1-benzofuran-2-yl)sulfonyl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 122696042 |
| Molecular Formula | C26H21FN4O4S |
| Molecular Weight | 504.54 g/mol |
| Exact Mass | 504.13 |
| IUPAC Name | N-[[4-(4-cyanophenyl)-2-pyridinyl]methyl]-1-[(5-fluoro-1-benzofuran-2-yl)sulfonyl]pyrrolidine-2-carboxamide |
| SMILES | N#Cc1ccc(-c2ccnc(CNC(=O)C3CCCN3S(=O)(=O)c3cc4cc(F)ccc4o3)c2)cc1 |
| InChI | InChI=1S/C26H21FN4O4S/c27-21-7-8-24-20(12-21)14-25(35-24)36(33,34)31-11-1-2-23(31)26(32)30-16-22-13-19(9-10-29-22)18-5-3-17(15-28)4-6-18/h3-10,12-14,23H,1-2,11,16H2,(H,30,32) |
| InChIKey | XVUHSIGTBITHKI-UHFFFAOYSA-N |
| XLogP | 3.98 |
| TPSA | 116.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 504.54 |
| LogP ≤ 5 | 3.98 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122696042 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.